药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Dixyrazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dixyrazine.
Potassium cation
Imipramine oxide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Imipramine oxide.
Potassium cation
Vinylbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vinylbital.
Potassium cation
Mephenoxalone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mephenoxalone.
Potassium cation
Fazadinium bromide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fazadinium bromide.
Potassium cation
Cyclobarbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cyclobarbital.
Potassium cation
Methylpentynol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methylpentynol.
Potassium cation
Vinyl ether
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vinyl ether.
Potassium cation
Niaprazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Niaprazine.
Potassium cation
Mosapramine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mosapramine.
Potassium cation
Fluanisone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluanisone.
Potassium cation
Hexapropymate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexapropymate.
Potassium cation
Alcuronium
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alcuronium.
Potassium cation
Loprazolam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Loprazolam.
Potassium cation
Pridinol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pridinol.
Potassium cation
Fabomotizole
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fabomotizole.
Potassium cation
Phenazocine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenazocine.
Potassium cation
Phenoperidine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenoperidine.
Potassium cation
Oxiracetam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxiracetam.
Potassium cation
Diethyl ether
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diethyl ether.